Northern Trust Corp reduced its holdings in shares of Petmed Express Inc (NASDAQ:PETS) by 1.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 287,544 shares of the company’s stock after selling 5,097 shares during the period. Northern Trust Corp owned about 1.39% of Petmed Express worth $6,688,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of PETS. Capital Investment Advisory Services LLC bought a new position in Petmed Express during the fourth quarter valued at approximately $26,000. Quantamental Technologies LLC bought a new position in Petmed Express during the fourth quarter valued at approximately $71,000. Oregon Public Employees Retirement Fund bought a new position in shares of Petmed Express in the fourth quarter worth approximately $183,000. First Hawaiian Bank bought a new position in shares of Petmed Express in the fourth quarter worth approximately $193,000. Finally, Gabelli Funds LLC bought a new position in shares of Petmed Express in the fourth quarter worth approximately $228,000. Institutional investors and hedge funds own 95.04% of the company’s stock.
PETS opened at $22.28 on Wednesday. The stock has a market capitalization of $463.72 million, a PE ratio of 11.10 and a beta of 0.51. Petmed Express Inc has a 1 year low of $20.25 and a 1 year high of $46.83.
Petmed Express (NASDAQ:PETS) last posted its quarterly earnings results on Tuesday, January 22nd. The company reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by ($0.10). The company had revenue of $60.10 million during the quarter, compared to analysts’ expectations of $64.22 million. Petmed Express had a return on equity of 32.89% and a net margin of 14.43%. Petmed Express’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.44 EPS.
PETS has been the topic of several recent analyst reports. BidaskClub upgraded shares of Petmed Express from a “sell” rating to a “hold” rating in a report on Wednesday, January 16th. Craig Hallum dropped their price target on Petmed Express from $25.00 to $18.00 and set a “sell” rating for the company in a research note on Wednesday, January 23rd. Finally, ValuEngine lowered Petmed Express from a “hold” rating to a “sell” rating in a research note on Monday, February 4th. Three equities research analysts have rated the stock with a sell rating and two have given a hold rating to the company. Petmed Express currently has an average rating of “Sell” and a consensus price target of $28.00.
COPYRIGHT VIOLATION WARNING: This report was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2019/04/17/northern-trust-corp-sells-5097-shares-of-petmed-express-inc-pets.html.
Petmed Express Company Profile
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Further Reading: Google Finance Portfolio
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.